As of November 2026 Generate Biomedicines has a market cap of NZ$3.18 Billion. This makes Generate Biomedicines the world's 5110th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 3rd, 2026 the market cap of Generate Biomedicines was reported to be: